Skip to main content

Schizophrenia Clinical Pearls

Hara Oyedeji
Clinical Pearls
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Kristian Dambrino, MSN
Videos
04/08/2025
Kristian Dambrino, MSN, APRN, PMHNP
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member...
04/08/2025
Psych Congress Network
Andrew Penn
Clinical Pearls
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
Andrew Penn, PMHNP-BC
Clinical Pearls
12/05/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn,...
12/05/2024
Psych Congress NP Institute
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych
Clinical Pearls
12/05/2024
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C,...
12/05/2024
Psych Congress NP Institute
Jonathan Meyer
Clinical Pearls
10/09/2024
Jonathan Meyer, MD
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into...
10/09/2024
Psych Congress NP Institute
amber hoberg
Clinical Pearls
08/20/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN,...
08/20/2024
Psych Congress NP Institute
Desiree Matthews
Clinical Pearls
07/19/2024
Desiree Matthews, PHMNP-BC
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the...
07/19/2024
Psych Congress NP Institute